SCHEMBL292245

SCHEMBL292245

CC(C)(C)OC(=O)N1CC(=O)N(c2ccccc2O)CC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
BCHE P06276 1/20 0.39
SMARCA2 P51531 2/20 0.38
SMARCA4 P51532 2/20 0.38
PBRM1 Q86U86 2/20 0.38
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
KDM1A O60341 1/20 0.36
USP30 Q70CQ3 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
REN P00797 2/20 0.34
BUB1 O43683 1/20 0.34
MAPK1 P28482 1/20 0.34
RORC P51449 2/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292987 0.88 MAPT (0.41) NR1H2NR1H3BCHEHDAC1HDAC6
SCHEMBL291695 0.87 REN (0.45) REN
SCHEMBL293228 0.86 REN (0.44) BCHESMN1; SMN2REN
SCHEMBL27776020 0.84 HDAC1 (0.36) NR1H2NR1H3BCHEHDAC1HDAC6
SCHEMBL292539 0.84 NR1H2 (0.45) NR1H2NR1H3BCHEGAASMN1; SMN2
SCHEMBL293149 0.83 SCN9A (0.41) NR1H2NR1H3BCHESCN5ASCN9A
SCHEMBL292682 0.82 OPRM1 (0.35) GAAREN
SCHEMBL293123 0.82 REN (0.48) NR1H2NR1H3BCHEGAAHDAC1
SCHEMBL291388 0.81 REN (0.48) BCHEGAAHDAC1HDAC6KDM1A
SCHEMBL291213 0.81 SNRNP200 (0.41) GAASMN1; SMN2HDAC1HDAC6REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101511799-B Cyclic amine compound DAIICHI SANKYO CO LTD 2012-05-30 CN disclosed
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
CN-101511799-A Cyclic amine compound DAIICHI SANKYO CO LTD (JP) 2009-08-19 CN disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 NR1H2 45/4885NR1H3 41/4885BCHE 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.